Brett Quave, MD
Pain Medicine · Medford, ORNPI 1013911361
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,161 of the $11,691 with a category attached, or 69.8%. 32 manufacturers reported payments, led by Boston Scientific at 32.2% of the total. Reporting peaked in 2022 at $3,301 and has fallen 61.5% since, to $1,271 in 2025.
Across 360 payments — averaging $32.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Relievant Medsystems, Inc.$2K
- Nalu Medical, Inc.$2K
- Pacira Pharmaceuticals Incorporated$966
- Medtronic$720
- Saluda Medical Americas, Inc.$608
- plus $2K from 26 others
What the payments were for
- Travel & lodging$3,53030%
- Food & beverage$8,16170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 195 | $3,759 |
| Relievant Medsystems, Inc. | 12 | $1,940 |
| Nalu Medical, Inc. | 17 | $1,668 |
| Pacira Pharmaceuticals Incorporated | 3 | $966 |
| Medtronic(2 entities) | 17 | $720 |
| Saluda Medical Americas, Inc. | 14 | $608 |
| Collegium Pharmaceutical, Inc. | 28 | $366 |
| Stimwave Technologies Incorporated | 5 | $276 |
| Daiichi Sankyo Inc. | 23 | $250 |
| Curonix LLC | 3 | $158 |
| AbbVie(2 entities) | 7 | $135 |
| Amgen | 5 | $96 |
| MML US, Inc. | 4 | $88 |
| SPR Therapeutics, Inc | 1 | $81 |
| Painteq LLC | 1 | $79 |
| Flowonix Medical Incorporated | 1 | $73 |
| Pfizer | 5 | $69 |
| Vertos Medical, Inc. | 2 | $62 |
| Piramal Critical Care | 2 | $30 |
| Radius Health, Inc. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $29 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| Antares Pharma, Inc. | 1 | $23 |
| Tersera Therapeutics LLC | 2 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Abbott | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Saol Therapeutics Inc. | 1 | $14 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,691 in reported general payments places this provider in the 75th percentile of 57 pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 22 | $1,622 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $1,507 |
| Oxycodone Hcl | 65 | $1,080 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $591 |
| Tizanidine Hcl | 45 | $275 |
| Gabapentin | 17 | $268 |
| Lorazepam | 28 | $15 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Medford
- Joseph SavinoMedford$95K
- Shawn SillsMedford$28K
- Alan HsuMedford$5K
- Vishal KhemlaniTualatin$338K
- Robert HerosTualatin$299K
- Kimberly MauerPortland$59K
- Stuart RosenblumPortland$31K
- Andrew OhPortland$30K
- Adrian AnthonyGresham$28K
- Adam KempEugene$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.